Fol. Biol. 2015, 61, 8-13
https://doi.org/10.14712/fb2015061010008
VLA4 Gene Polymorphism and Susceptibility to Multiple Sclerosis in Slovaks
References
1. 2012) Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases. Autoimmun. Rev. 11, 276-280.
< , J. M., Kim-Howard, X., Prahalad, S., Cherñavsky, A., Cañas, C., Rojas-Villarraga, A., Bohnsack, J., Jonsson, R., Bolstad, A. I., Brun, J. G., Cobb, B., Moser, K. L., James, J. A., Harley, J. B., Nath, S. K. (https://doi.org/10.1016/j.autrev.2011.07.007>
2. 2007) The role of VLA4 polymorphisms in multiple sclerosis: an association study. J. Neuroimmunol. 189, 125-128.
< , V., Cittadella, R., Valentino, P., Condino, F., La Russa, A., Liguori, M., Manna, I., Spadafora, P., Nisticò, R., Pirritano, D., Clodomiro, A., Quattrone, A. (https://doi.org/10.1016/j.jneuroim.2007.06.015>
3. 2013). The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania. BMC Neuro. 13, 77.
< , R., Rastenyte, D., Vaitkus, A., Mickeviciene, D., Skrodeniene, E., Vitkauskiene, A., Uloziene, I. (https://doi.org/10.1186/1471-2377-13-77>
4. 2013) Association of HLA-DRB1*1501 tagging rs3135388 gene polymorphism with multiple sclerosis. J. Neuroimmunol. 255, 92-96.
< , Y., Vasku, A., Stourac, P., Hladikova, M., Fiala, A., Bednarik, J. (https://doi.org/10.1016/j.jneuroim.2012.10.014>
5. 1995) α4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80, 413-422.
< , C., Bargatze, R. F., Campbell, J. J., von Andrian, U. H., Szabo, M. C., Hasslen, S. R., Nelson, R. D., Berg, E. L., Erlandsen, S. L., Butcher, E. C. (https://doi.org/10.1016/0092-8674(95)90491-3>
6. 2010) HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis. Mult. Scler. 16, 21-29.
< , D. G., Barreira, A. A., dos Santos, A. C., Kaimen- Maciel, D. R., Matiello, M., Costa, R. M., Deghaide, N. H., Costa, L. S., Louzada-Junior, P., Diniz, P. R., Comini- Frota, E. R., Mendes-Junior, C. T., Donadi, E. A. (https://doi.org/10.1177/1352458509350741>
7. Buc, M. (2013) Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis. Mediat. Inflamm. Article ID 963748, 11 pages.
<https://doi.org/10.1155/2013/963748>
8. 2009) Association of the α4 integrin subunit gene (ITGA4) with autism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B, 1147-1151.
< , C., Coutinho, A. M., Almeida, J., Lontro, R., Lobo, C., Miguel, T. S., Martins, M., Gallagher, L., Conroy, J., Gill, M., Oliveira, G., Vicente, A. M. (https://doi.org/10.1002/ajmg.b.30940>
9. 2008) A Taqman assay for high-throughput genotyping of the multiple sclerosis-associated HLADRB1* 1501 allele. Tissue Antigens 72, 401-403.
< , A., Walton, A., Ban, M., Dubois, B., Compston, A., Sawcer, S. (https://doi.org/10.1111/j.1399-0039.2008.01101.x>
10. 2007) International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357, 851-862.
, D. A., Compston, A., Sawcer, S., Lander, E. S., Daly, M. J., De Jager, P. L., de Bakker, P. I., Gabriel, S. B., Mirel, D. B., Ivinson, A. J., Pericak-Vance, M. A., Gregory, S. G., Rioux, J. D., McCauley, J. L., Haines, J. L., Barcellos, L. F., Cree, B., Oksenberg, J. R., Hauser, S. L. (
11. 2003) Frequencies of α4 A3061G variants and identification of three new variants of the human integrin α4-subunit. Mol. Immunol. 39, 855-860.
< , G. A., Kiesewetter, H., Salama, A. (https://doi.org/10.1016/S0161-5890(03)00009-9>
12. 2000). Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene 260, 1-12.
< , K., Moser, M., Schorle, H., Buettner, R. (https://doi.org/10.1016/S0378-1119(00)00454-6>
13. 2013). Genetic risk variants in African Americans with multiple sclerosis. Neurology 81, 219-227.
< , N., Gourraud, P. A., Harbo, H. F., Caillier, S. J., Santaniello, A., Khankhanian, P., Maiers, M., Spellman, S., Cereb, N., Yang, S., Pando, M. J., Piccio, L., Cross, A. H., De Jager, P. L., Cree, B. A., Hauser, S. L., Oksenberg, J. R. (https://doi.org/10.1212/WNL.0b013e31829bfe2f>
14. 1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33, 1444-1452.
< , J. F. (https://doi.org/10.1212/WNL.33.11.1444>
15. 2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat. Genet. 45, 1452-1458.
< , J. C., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., DeStafano A. L., Bis, J. C., Beecham, G. W., Grenier-Boley, B., Russo, G. et al. (https://doi.org/10.1038/ng.2802>
16. 2005) A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat. Genet. 37, 1108-1112.
< , M. R., Montpetit, A., Cader, M. Z., Saarela, J., Dyment, D. A., Tiislar, M., Ferretti, V., Tienari, P. J., Sadovnick, A. D., Peltonen, L., Ebers, G. C., Hudson, T. J. (https://doi.org/10.1038/ng1647>
17. 2000) HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann. Neurol. 48, 211-219.
< , T., Ligers, A., Olsson, T., Andersson, M., Olerup, O., Hillert, J. (https://doi.org/10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.0.CO;2-R>
18. 1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215.
< , S. A., Dykes, D. D., Polesky, H. F. (https://doi.org/10.1093/nar/16.3.1215>
19. 2009) Gender and sex hormones in multiple sclerosis pathology and therapy. Front. Biosci. (Landmark Ed.) 14, 4477-4515.
< , A. (https://doi.org/10.2741/3543>
20. 2005) Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis. Mult. Scler. 11, 568-572.
< , P., Miller, D., Riester, K., Yang, M., Panzara, M., Dalton, C., Miszkiel, K., Khan, O., Rice, G., Sheremata, W., International Natalizumab Trial Group (https://doi.org/10.1191/1352458505ms1205oa>
21. 2011) Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis. Neurology 76, 1858-1865.
< , P. W., Goodman, A., Kappos, L., Lublin, F. D., Miller, D. H., Polman, C., Rudick, R. A., Aschenbach, W., Lucas, N. (https://doi.org/10.1212/WNL.0b013e31821e7c8a>
22. 2007) ITGA4 polymorphisms and susceptibility to multiple sclerosis. J. Neuroimmunol. 189, 151-157.
< , C., Roos, I. M., Antiguedad, A., Aransay, A. M., Hillert, J., Vandenbroeck, K. (https://doi.org/10.1016/j.jneuroim.2007.07.006>
23. 2009). HLA-DRB1 and multiple sclerosis in Argentina. Eur. J. Neurol. 16, 427–429.
< , L., Larriba, J., Redal, M. A., Rojas, J. I., Argibay, P. F., Cristiano, E. (https://doi.org/10.1111/j.1468-1331.2008.02523.x>
24. 2012) Single nucleotide polymorphisms in multiple sclerosis, disease susceptibility and treatment response biomarkers. Immunol. Res. 52, 42-52.
< , V., Popadic, D., Savic, E., Markovic, M., Drulovic, J., Mostarica-Stojkovic, M. (https://doi.org/10.1007/s12026-012-8273-y>
25. 2012) Genetic background of multiple sclerosis. Autoimmun. Rev. 11, 163-166.
< , A. D. (https://doi.org/10.1016/j.autrev.2011.05.007>
26. 2007) HLADR15 haplotype and multiple sclerosis: a HuGE review. Am. J. Epidemiol. 165, 1097-1109.
< , H., Williamson, D., Ashley-Koch, A. (https://doi.org/10.1093/aje/kwk118>
27. 2009) HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis. Tissue Antigens 74, 17-21.
< , J., Butzkueven, H., Marriott, M., Chapman, C., Tubridy, N., Tait, B. D., Varney, M. D., Taylor, B. V., Foote, S. J.; ANZgene Consortium, Kilpatrick, T. J., Rubio, J. P. (https://doi.org/10.1111/j.1399-0039.2009.01262.x>
28. 1995) Identification of two variants of the human integrin α4 subunit. Mol. Immunol. 32, 1453-1454.
< , M., McIntyre, B. W. (https://doi.org/10.1016/0161-5890(96)00001-6>
29. 2009) The tag SNP for HLA-DRB1*1501, rs3135388, is significantly associated with multiple sclerosis susceptibility: cost-effective highthroughput detection by real-time PCR. Clin. Chim. Acta 406, 27-30.
< , M., Stanković, A., Dincić, E., Popović, M., Popović, S., Raicević, R., Alavantić, D. (https://doi.org/10.1016/j.cca.2009.05.004>